Sponsor · clinical trials

University of Alberta clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada, Australia, Czechia, Poland, Spain, Austria, France, Italy, Ireland, Germany, Switzerland, South Korea and Norway registers with University of Alberta as lead sponsor. Synced 14 Nov 2026

180Current trials

122Recruiting now

25Drugs in these trials

13Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 14 Nov 2026 · Editorial standards

At a glance

University of Alberta is the lead sponsor of 180 current clinical trials in our Canada, Australia, Czechia, Poland, Spain, Austria, France, Italy, Ireland, Germany, Switzerland, South Korea and Norway registers. 122 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Ciprofloxacin, Furosemide and Metformin. The most-studied condition is Prostate Cancer.

ClinicalTrials.gov trials by status

Recruiting12268%
Not yet open2916%
Active, closed2514%
By invitation42%

Trials by phase

Not applicable9452%
Observational3519%
Phase 21911%
Phase 4116%
Phase 174%
Phase 353%
Phase 2/353%
Early Phase 132%
Phase 1/211%

Clinical trials sponsored by University of Alberta

180 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy NCT06375369 · ClinicalTrials.gov ↗ · Tracheostomy	Not applicable	Recruiting	2024-09	Canada
HIIT in Pediatric Heart Transplant Recipients (MedBIKE™) NCT05451979 · ClinicalTrials.gov ↗ · Pediatric ALL, Transplant; Failure, Heart	Not applicable	Recruiting	2022-02	Canada
Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease NCT06325280 · ClinicalTrials.gov ↗ · Pediatric ALL, Congenital Heart Disease, Heart Transplantation	Observational	Recruiting	2025-01	Canada
Trifecta-Lung cfDNA-MMDx Study NCT05837663 · ClinicalTrials.gov ↗ · Lung Transplantation	Observational	Recruiting	2023-11	Austria, Czechia, Canada, Australia
Augmented Renal Clearance in Neurocritical Care NCT07410624 · ClinicalTrials.gov ↗ · TBI (Traumatic Brain Injury), Status Epilepticus, Bacterial Meningitis	Observational	Recruiting	2021-10	Canada
High-intensity Walking Rehabilitation in Outpatient Subacute Spinal Cord Injury NCT07553923 · ClinicalTrials.gov ↗ · Spinal Cord Injuries (SCI)	Not applicable	Recruiting	2026-05	Canada
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. NCT06626022 · ClinicalTrials.gov ↗ · Prostate Cancer Screening	Phase 3	Recruiting	2025-05	France, Spain, Norway, Canada
Sotatercept in Pulmonary Arterial Hypertension NCT07140484 · ClinicalTrials.gov ↗ · Pulmonary Artery Hypertension Drug: Sotatercept	Phase 4	Recruiting	2025-10	Canada
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation NCT02670408 · Cardiac Transplant Disorder	Observational	Recruiting	2016-01	France, Spain, Italy, Austria, Czechia, Canada, Australia
Photobiomodulation for Pediatric Hypertrophic Tonsils NCT05459935 · ClinicalTrials.gov ↗ · Pediatric Sleep Apnea, Obstructive Sleep Apnea, Tonsils Hypertrophy	Not applicable	Recruiting	2022-10	Canada
LFMT vs Placebo in New Biologic Start for Ulcerative Colitis NCT05327790 · ClinicalTrials.gov ↗ · Ulcerative Colitis Drug: Fecal microbiota	Phase 2	Recruiting	2022-06	Canada
Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury? NCT05467215 · ClinicalTrials.gov ↗ · Spinal Cord Injuries	Early Phase 1	Recruiting	2022-07	Canada
Timing of Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy NCT07636135 · ClinicalTrials.gov ↗ · Cervical Myelopathy	Not applicable	Recruiting	2026-07	Canada
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation NCT01299168 · Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards	Observational	Recruiting	2011-05	Ireland, Germany, France, Spain, Poland, Switzerland, Austria, Czechia, Canada, South Korea
Taurine Supplementation in Long COVID NCT06721949 · ClinicalTrials.gov ↗ · Long COVID Drug: Taurine	Phase 2/3	Recruiting	2025-11	Canada
Personalized Anti-Inflammatory Fibres in Ulcerative Colitis NCT06515210 · ClinicalTrials.gov ↗ · Ulcerative Colitis	Not applicable	Recruiting	2025-06	Canada
Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? NCT05923970 · ClinicalTrials.gov ↗ · Vaccination Failure, Vaccine Response Impaired	Observational	Recruiting	2024-11	Canada
Physiotherapy Dry Needling Accuracy NCT06845969 · ClinicalTrials.gov ↗ · Dry Needling, Physiotherapy	Not applicable	Recruiting	2025-04	Canada
Deep Brain Reorienting for Posttraumatic Stress Disorder NCT07840417 · ClinicalTrials.gov ↗ · Posttraumatic Stress Disorder (PTSD), Posttraumatic Stress Symptom	Not applicable	Recruiting	2026-09	Canada
18F-DOPA II - PET Imaging Optimization NCT04706910 · ClinicalTrials.gov ↗ · Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease Drug: Furosemide	Phase 3	Recruiting	2021-01	Canada
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) NCT06705764 · ClinicalTrials.gov ↗ · Severe Asthma Drug: Tezepelumab	Phase 4	Recruiting	2026-05	Canada
Trifecta-Kidney cfDNA-MMDx Study NCT04239703 · ClinicalTrials.gov ↗ · Kidney Transplant Rejection	Observational	Recruiting	2019-12	Germany, Poland, Switzerland, Czechia, Canada, Australia
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation NCT02812290 · ClinicalTrials.gov ↗ · Lung Transplant Rejection	Observational	Recruiting	2016-05	Poland, Austria, Czechia, Canada, Australia
Feasibility Trial for a Right Ventricular Failure Platform Trial NCT06570473 · ClinicalTrials.gov ↗ · Pulmonary Hypertension, Right Ventricular Dysfunction, Right Heart Failure Drugs: Dapagliflozin, Ranolazine	Phase 2	Recruiting	2025-07	Canada
Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women NCT05432856 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Cardiovascular Morbidity, Metabolic Disease	Not applicable	Recruiting	2024-03	Canada
COgnitioN With VERiciGuat Evaluation in Heart Failure NCT06601465 · ClinicalTrials.gov ↗ · Heart Failure, Cognitive Impairment Drug: Vericiguat	Phase 2	Recruiting	2025-06	Canada
Behavioral Intervention and Guided Stepping Training Early Post-Stroke NCT07702643 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Recruiting	2026-08	Canada
Connecting Today to Combat Social Isolation and Loneliness NCT07182019 · ClinicalTrials.gov ↗ · Dementia in Nursing Home, Family, Remote Visits	Not applicable	Recruiting	2026-06	Canada
Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy NCT06895902 · ClinicalTrials.gov ↗ · Facial Nerve Palsy, Corneal Exposure, Paralytic Lagophthalmos	Early Phase 1	Recruiting	2025-04	Canada
ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial NCT06038032 · ClinicalTrials.gov ↗ · Endometrial Cancer	Not applicable	Recruiting	2024-03	Canada
Transcutaneous Spinal Cord Stimulation for Upper Extremity Function NCT06596369 · ClinicalTrials.gov ↗ · Spinal Cord Injuries, Stroke	Phase 2/3	Recruiting	2024-06	Canada
Trifecta-Heart cfDNA-MMDx Study NCT04707872 · ClinicalTrials.gov ↗ · Heart Transplant Rejection	Observational	Recruiting	2021-06	Spain, Italy, Poland, Czechia, Canada, Australia
Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial NCT04149223 · ClinicalTrials.gov ↗ · Cirrhosis, Liver	Not applicable	Recruiting	2019-06	Canada
The PROTECT-HIE Pilot Trial NCT07406477 · ClinicalTrials.gov ↗ · Hypoxic-ischemic Encephalopathy (HIE) Drug: Dobutamine	Phase 2	Recruiting	2026-10	Canada
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) NCT06446739 · ClinicalTrials.gov ↗ · Acute Kidney Injury, Dialysis; Complications	Not applicable	Recruiting	2024-11	Canada
Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site) NCT05058612 · ClinicalTrials.gov ↗ · Vasoplegia Drug: Midodrine	Phase 4	Recruiting	2021-03	Canada
Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover Trial NCT06903416 · ClinicalTrials.gov ↗ · Spinal Cord Injury Cervical	Phase 2/3	Recruiting	2025-05	Canada
MRI Assessment of Pulmonary Edema in Acute Heart Failure NCT03999138 · ClinicalTrials.gov ↗ · Acute Heart Failure, Pulmonary Edema With Heart Failure	Observational	Recruiting	2019-01	Canada
The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children NCT07090057 · ClinicalTrials.gov ↗ · Idiopathic Toe Walking, Cerebral Palsy, Hereditary Spastic Paraparesis	Not applicable	Recruiting	2023-03	Canada
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors NCT04888481 · ClinicalTrials.gov ↗ · Neuroendocrine Tumors	Phase 2	Recruiting	2022-02	Canada
The Adult Degenerative Scoliosis Exercise Trial (Pilot Study) NCT03862417 · ClinicalTrials.gov ↗ · Degenerative Scoliosis	Not applicable	Recruiting	2020-09	Canada
Fish Oil, Metformin and Heart Health in PCOS NCT06424860 · ClinicalTrials.gov ↗ · PCOS, Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Drug: Metformin	Phase 1	Recruiting	2025-11	Canada
Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients NCT07359261 · ClinicalTrials.gov ↗ · Respiratory Failure	Phase 2	Recruiting	2026-02	Canada
Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies NCT07339852 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Hypertension, Hyperlipidaemia	Not applicable	Recruiting	2025-10	Canada
Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study NCT06555393 · ClinicalTrials.gov ↗ · High Blood Sugar, High Blood Pressure, Overweight and Obesity	Phase 1	Recruiting	2026-02	Canada
Body Structure and Capacity Evaluation of Adults With Scoliosis NCT05538871 · ClinicalTrials.gov ↗ · Scoliosis	Observational	Recruiting	2019-05	Canada
Cycling-Based Aerobic Exercise Intervention for Individuals With Chemotherapy-Induced Peripheral Neuropathy (CIPN) NCT07150117 · ClinicalTrials.gov ↗ · Cancer, Adults	Not applicable	Recruiting	2026-01	Canada
3D Assessment of RV Function in Patients Undergoing LVAD Implantation NCT05376254 · ClinicalTrials.gov ↗ · Heart Failure	Observational	Recruiting	2022-03	Canada
Fibroscan to Guide Post Transplant Immunosuppression Minimization NCT07206277 · ClinicalTrials.gov ↗ · Immunosuppression	Not applicable	Recruiting	2025-12	Canada
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation NCT03193151 · ClinicalTrials.gov ↗ · Liver Dysfunction	Observational	Recruiting	2017-12	Poland, Canada, Australia
Trained vs. Untrained: Lower Extremity Pressure Changes NCT07897357 · ClinicalTrials.gov ↗ · Trained Athletes, Untrained	Not applicable	Recruiting	2026-10	Canada
Antibiotic Prophylaxis for Bladder Botox NCT04444440 · ClinicalTrials.gov ↗ · Idiopathic Overactive Bladder, Postoperative Urinary Tract Infection Drug: Ciprofloxacin	Phase 4	Recruiting	2021-06	Canada
Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis NCT06681142 · ClinicalTrials.gov ↗ · Osteoarthritis (OA) of the Knee, Physiotherapy, Pharmacy	Not applicable	Recruiting	2025-08	Canada
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study NCT07685639 · ClinicalTrials.gov ↗ · ACS (Acute Coronary Syndrome), Hyperlipidemia, Dyslipidemia	Not applicable	Recruiting	2026-08	Canada
Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent NCT07524439 · ClinicalTrials.gov ↗ · Fecal Incontinence, Urinary Incontinence, Diaper Rash	Not applicable	Recruiting	2026-05	Canada
Reaching the Unreached: Home-Based Telerehabilitation for Stroke Survivors NCT07467785 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Recruiting	2026-06	Canada
Lumbar Brace Deployment in the Emergency Department for Benign Low Back Pain NCT03829631 · ClinicalTrials.gov ↗ · Low Back Pain, Brace, Emergencies	Not applicable	Recruiting	2019-06	Australia
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD NCT05061368 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease Drug: Sildenafil	Phase 2	Recruiting	2022-03	Canada
Nimodipine Variability in SAH NCT07065903 · ClinicalTrials.gov ↗ · Subarachnoid Aneurysm Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal	Observational	Recruiting	2024-05	Canada
Effectiveness of NOA OATMAD NCT07111962 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Observational	Recruiting	2025-09	Canada
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes NCT05203640 · ClinicalTrials.gov ↗ · Type 1 Diabetes	Not applicable	Recruiting	2022-04	Canada
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study NCT05645510 · ClinicalTrials.gov ↗ · Cancer, Tyrosine Kinase Mutation, Breast Cancer	Observational	Recruiting	2022-11	Canada
Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome NCT05395715 · ClinicalTrials.gov ↗ · Cubital Tunnel Syndrome, Electrical Stimulation	Not applicable	Recruiting	2022-04	Canada
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD NCT07187830 · ClinicalTrials.gov ↗ · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight	Observational	Recruiting	2026-02	Canada
Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer NCT06072911 · ClinicalTrials.gov ↗ · Prostate Cancer, Incontinence, Metabolic Disease	Not applicable	Recruiting	2024-02	Canada
Hemianopsia Rehabilitation After Stroke or Brain Injury NCT06241209 · ClinicalTrials.gov ↗ · Hemianopsia, Visual Field Defect, Peripheral, Visual Impairment	Not applicable	Recruiting	2024-01	Canada
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass NCT07272837 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Obesity, Semaglutide	Observational	Recruiting	2026-05	Canada
Antibiotic Prophylaxis for Neurogenic Bladder Botox NCT04791579 · ClinicalTrials.gov ↗ · Neurogenic Bladder, Post-operative Urinary Tract Infections Drug: Ciprofloxacin	Phase 2	Recruiting	2025-02	Canada
Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment NCT05733676 · ClinicalTrials.gov ↗ · White Spot Lesions, Orthodontic Appliance Complication, Caries Arrested	Not applicable	Recruiting	2023-05	Canada
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program NCT05226624 · Neonatal Abstinence Syndrome	Not applicable	Recruiting	2023-10	Canada
Fasted Exercise Training in Type 1 Diabetes (FED-T1D) NCT06748963 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 1	Not applicable	Recruiting	2025-01	Canada
Sleep Disordered Breathing, Endothelial Function, and Adverse Events in Pregnancy NCT05908591 · ClinicalTrials.gov ↗ · Pregnancy Related, Sleep-Disordered Breathing	Observational	Recruiting	2023-01	Canada
Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion NCT04190953 · ClinicalTrials.gov ↗ · Apnea, Airway Obstruction, Nasal, Mandible Small	Not applicable	Recruiting	2020-02	Canada
Protein Needs Study NCT04144907 · ClinicalTrials.gov ↗ · Colorectal Cancer, Breast Cancer	Not applicable	Recruiting	2021-04	Canada
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease NCT06053164 · ClinicalTrials.gov ↗ · Fibrotic Interstitial Lung Disease	Phase 2	Recruiting	2025-07	Canada
Using Neurotechology to Help Children With Physical Disability Due to Cerebral Palsy NCT07269353 · ClinicalTrials.gov ↗ · Hemiparetic Cerebral Palsy	Not applicable	Recruiting	2026-02	Canada
Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus NCT06531083 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Trismus	Not applicable	Recruiting	2025-03	Canada
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population NCT07401680 · ClinicalTrials.gov ↗ · Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection	Phase 1	Recruiting	2026-03	Canada
PSMA-Guided Ablation of the Prostate NCT06003556 · ClinicalTrials.gov ↗ · Prostate Cancer, Localized Prostate Carcinoma	Phase 2	Recruiting	2024-04	Canada
Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet NCT06683105 · ClinicalTrials.gov ↗ · Inflammatory Bowel Disease (IBD)	Not applicable	Recruiting	2026-03	Canada
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea NCT05497180 · ClinicalTrials.gov ↗ · Sleep Apnea, Obstructive	Phase 1	Recruiting	2022-07	Canada
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences NCT05997732 · ClinicalTrials.gov ↗ · Vasoconstriction, Vasodilation Drugs: Phenylephrine Hydrochloride, Propranolol	Phase 4	Recruiting	2023-10	Canada
An Adaptive Design Study of MTX228 NCT06474598 · ClinicalTrials.gov ↗ · Type 1 Diabetes Mellitus	Phase 2	Recruiting	2024-11	Canada
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN NCT06949436 · ClinicalTrials.gov ↗ · Trigeminal Neuralgia (TN)	Phase 2	Recruiting	2025-07	Canada
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation NCT05579678 · ClinicalTrials.gov ↗ · Allogeneic Disease	Observational	Recruiting	2022-11	Canada
Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2) NCT07055113 · ClinicalTrials.gov ↗ · Knee Osteoarthritis, Hip Osteoarthritis	Not applicable	Recruiting	2025-07	Canada
Utilizing an EEG-Based BCI Game to Evaluate Cognitive Skills in Children With Motor Impairments NCT07109830 · ClinicalTrials.gov ↗ · Children With Motor Impairments	Observational	Recruiting	2025-11	Canada
Evaluating AI for the Translation of KM Resources NCT07666399 · ClinicalTrials.gov ↗ · Communication Research	Not applicable	Recruiting	2026-10	Canada
Breakthrough CMV Lung Transplant -Multicentre NCT04439916 · ClinicalTrials.gov ↗ · Cytomegalovirus Infections	Observational	Recruiting	2021-01	Canada
Exercise and the Menstrual Cycle in Type 1 Diabetes NCT05188014 · ClinicalTrials.gov ↗ · Type 1 Diabetes	Not applicable	Recruiting	2022-03	Canada
rTMS With and Without Text4Support for the Treatment of Resistant Depression. NCT05570344 · ClinicalTrials.gov ↗ · Depressive Disorder, Treatment-Resistant	Not applicable	Recruiting	2023-02	Canada
Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE) NCT04580225 · ClinicalTrials.gov ↗ · Wrist Arthritis, Wrist Arthropathy, Scapholunate Advanced Collapse	Not applicable	Recruiting	2021-01	Canada
Early Videocapsule Endoscopy for Upper Gastrointestinal Bleeding NCT05108844 · ClinicalTrials.gov ↗ · Small Bowel Bleeding	Not applicable	Recruiting	2021-09	Canada
Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance NCT04578652 · ClinicalTrials.gov ↗ · Obesity, Childhood, Insulin Resistance Drug: Metformin	Phase 3	Recruiting	2021-10	Canada
Extended-Release Tacrolimus Following Liver Transplantation NCT05242315 · ClinicalTrials.gov ↗ · Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction Drug: Prograf	Phase 4	Recruiting	2022-05	Canada
Phototherapy for Non-responders to Oral Appliance Therapy for Obstructive Sleep Apnea NCT06960200 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Phase 2	Recruiting	2024-01	Canada
Telemonitoring of Hypertensive Patients With Chronic Kidney Disease NCT04098354 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases	Not applicable	Recruiting	2022-04	Canada
Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy NCT06989541 · ClinicalTrials.gov ↗ · Hypogammaglobulinemia, Acquired Drug: Immune Globulin (Human)	Observational	Recruiting	2025-06	Canada
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma NCT06280924 · ClinicalTrials.gov ↗ · Multiple Myeloma, Exercise, Prehabilitation	Not applicable	Recruiting	2024-08	Canada
Alberta Chiropractic SelfBack Study NCT06347991 · ClinicalTrials.gov ↗ · Chronic Low-back Pain	Not applicable	Recruiting	2024-05	Canada

Showing the 100 most recently updated of 180 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in University of Alberta trials

25 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in University of Alberta trials

284 conditions

Prostate Cancer4 Obstructive Sleep Apnea4 Spinal Cord Injuries4 Heart Failure4 Stroke4 Breast Cancer4Pediatric ALL3Ulcerative Colitis3 Acute Kidney Injury3 Type 1 Diabetes3 Congenital Heart Disease2 Pain2 Diabetes Mellitus, Type 22 Overweight and Obesity2 Long COVID2Physiotherapy2Cardiovascular Diseases2Metabolic Disease2Cirrhosis, Liver2Diabetes2Acute Heart Failure2Traumatic Brain Injury2 Neuroendocrine Tumors2 Cardiovascular Disease2

By trial register

Register	Trials	Recruiting
Clinical trials in Canada	179	121
Clinical trials in Australia	7	7
Clinical trials in Czechia	6	6
Clinical trials in Poland	5	5
Clinical trials in Spain	4	4
Clinical trials in Austria	4	4
Clinical trials in France	3	3
Clinical trials in Italy	3	2
Clinical trials in Ireland	2	1
Clinical trials in Germany	2	2
Clinical trials in Switzerland	2	2
Clinical trials in South Korea	1	1
Clinical trials in Norway	1	1

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Prostate Cancer

Sponsor	Trials
University Health Network, Toronto	12
Peking University First Hospital	12
Sunnybrook Health Sciences Centre	10
Sir Mortimer B. Davis - Jewish General Hospital	7
CHU de Quebec-Universite Laval	7
Jiangsu HengRui Medicine	6
European Organisation for Research and Treatment of Cancer - EORTC	5
British Columbia Cancer Agency	5
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	5
Universitaire Ziekenhuizen KU Leuven	5

Sponsors with the most current trials registered for this condition.

Questions about University of Alberta trials

How many clinical trials does University of Alberta sponsor?

University of Alberta is the lead sponsor of 180 current trials on ClinicalTrials.gov in our Canada, Australia, Czechia, Poland, Spain, Austria, France, Italy, Ireland, Germany, Switzerland, South Korea and Norway registers, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are University of Alberta trials recruiting?

Yes. 122 of its 180 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Alberta testing?

Its current trials name 25 drugs and biologicals as interventions. The most frequent are Ciprofloxacin (2), Furosemide (2), Metformin (2), 18F-PSMA-1007 (1) and Bupivacaine hydrochloride (1). The number in brackets is how many of its trials name each drug.

Does University of Alberta have clinical trials in Ireland?

Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.